Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice

Journal of Nutritional Biochemistry

Volumn 42, Issue , 2017, Pages 43-50

  Islam, Jahidul ^a   Sato, Shoko ^b   Watanabe, Kouichi ^a   Watanabe, Takaya ^a   Ardiansyah, ^a,c   Hirahara, Keisuke ^a   Aoyama, Yukihide ^a   Tomita, Shuhei ^d   Aso, Hisashi ^a   Komai, Michio ^a   Shirakawa, Hitoshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c BAKRIE UNIVERSITY   (Indonesia)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aryl hydrocarbon receptor; Dextran sodium sulfate; Tryptamine; Tryptophan; Ulcerative colitis

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CXCL2 CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRYPTOPHAN; TUMOR NECROSIS FACTOR; CHEMOKINE; CYTOKINE; DEXTRAN SULFATE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; PEROXIDASE; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; ENZYME MECHANISM; EPITHELIUM CELL; FEMALE; HOMEOSTASIS; IMMUNOMODULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; DIETARY SUPPLEMENT; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; CHEMOKINES; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; FEMALE; INTERLEUKINS; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIDASE; RECEPTORS, ARYL HYDROCARBON; STAT3 TRANSCRIPTION FACTOR; TRYPTOPHAN;

EID: 85009909922     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.12.019     Document Type: Article

References (41)

1. [1] Shizuma, T., Mori, H., Fukuyama, N., Protective effect of tryptophan against dextran sulfate sodium-induced experimental colitis. Turk J Gastroenterol 24:1 (2013), 30–35.
2. [2] Chami, B., Yeung, A.W., van Vreden, C., King, N.J., Bao, S., The role of CXCR3 in DSS-induced colitis. PLoS One, 9(7), 2014, e101622.
3. [3] Seril, D.N., Liao, J., Yang, G.Y., Yang, C.S., Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24:3 (2003), 353–362.
4. [4] Atreya, R., Neurath, M.F., New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunol 1:3 (2008), 175–182.
5. [5] Faubion, W.A. Jr., Loftus, E.V. Jr., Harmsen, W.S., Zinsmeister, A.R., Sandborn, W.J., The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121:2 (2001), 255–260.
6. [6] Hisamatsu, T., Okamoto, S., Hashimoto, M., Muramatsu, T., Andou, A., Uo, M., et al. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease. PLoS One, 7(1), 2012, e31131.
7. [7] Kim, C.J., Kovacs-Nolan, J.A., Yang, C., Archbold, T., Fan, M.Z., Mine, Y., L-tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem 21:6 (2010), 468–475.
8. [8] Palego, L., Betti, L., Rossi, A., Giannaccini, G., Tryptophan biochemistry: structural, nutritional, metabolic, and medical aspects in humans. J Amino Acids, 2016, 2016, 8952520.
9. [9] Keszthelyi, D., Troost, F.J., Masclee, A.A., Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol Motil 21:12 (2009), 1239–1249.
10. [10] Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:2 (2013), 372–385.
11. [11] Cheng, Y., Jin, U.H., Allred, C.D., Jayaraman, A., Chapkin, R.S., Safe, S., Aryl hydrocarbon receptor activity of tryptophan metabolites in young adult mouse colonocytes. Drug Metab Dispos 43:10 (2015), 1536–1543.
12. [12] Jin, U.H., Lee, S.O., Sridharan, G., Lee, K., Davidson, L.A., Jayaraman, A., et al. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol Pharmacol 85:5 (2014), 777–788.
13. [13] Williams, B.B., Van Benschoten, A.H., Cimermancic, P., Donia, M.S., Zimmermann, M., Taketani, M., et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe 16:4 (2014), 495–503.
14. [14] Sato, S., Shirakawa, H., Tomita, S., Tohkin, M., Gonzalez, F.J., Komai, M., The aryl hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A. Toxicol Appl Pharmacol 273:1 (2013), 90–99.
15. [15] Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya, M., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 13:2 (2011), 144–151.
16. [16] Vikström Bergander, L., Cai, W., Klocke, B., Seifert, M., Pongratz, I., Tryptamine serves as a proligand of the AhR transcriptional pathway whose activation is dependent of monoamine oxidases. Mol Endocrinol 26:9 (2012), 1542–1551.
17. [17] Furumatsu, K., Nishiumi, S., Kawano, Y., Ooi, M., Yoshie, T., Shiomi, Y., et al. A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig Dis Sci 56:9 (2011), 2532–2544.
18. [18] Zindl, C.L., Lai, J.F., Lee, Y.K., Maynard, C.L., Harbour, S.N., Ouyang, W., et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A 110:31 (2013), 12768–12773.
19. [19] Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 206:7 (2009), 1465–1472.
20. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:12 (2003), 1875–1886.
21. [21] Singh, N.P., Singh, U.P., Singh, B., Price, R.L., Nagarkatti, M., Nagarkatti, P.S., Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One, 6(8), 2011, e23522.
22. [22] Takamura, T., Harama, D., Matsuoka, S., Shimokawa, N., Nakamura, Y., Okumura, K., et al. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol 88:6 (2010), 685–689.
23. [23] Vowinkel, T., Mori, M., Krieglstein, C.F., Russell, J., Saijo, F., Bharwani, S., et al. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest 114:2 (2004), 260–269.
24. [24] Fernandez-Salguero, P., Pineau, T., Hilbert, D.M., McPhail, T., Lee, S.S., Kimura, S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268:5211 (1995), 722–726.
25. [25] Takayama, K., Matsui, E., Kobayashi, T., Inoue, H., Tsuruta, Y., Okamura, N., High-performance liquid chromatographic determination and metabolic study of sennoside a in daiokanzoto by mouse intestinal bacteria. Chem Pharm Bull (Tokyo) 59:9 (2011), 1106–1109.
26. [26] Nishiyama, Y., Kataoka, T., Yamato, K., Taguchi, T., Yamaoka, K., Suppression of dextran sulfate sodium-induced colitis in mice by radon inhalation. Mediators Inflamm, 2012, 2012, 239617.
27. [27] Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:2 (1979), 351–358.
28. [28] Islam, J., Shirakawa, H., Nguyen, T.K., Aso, H., Komai, M., Simultaneous analysis of serotonin, tryptophan and tryptamine levels in common fresh fruits and vegetables in Japan using fluorescence HPLC. Food Biosci 13 (2016), 56–59.
29. [29] Grady, W.M., Making the case for DCC and UNC5C as tumor-suppressor genes in the colon. Gastroenterology 133:6 (2007), 2045–2049.
30. [30] Bernardo, D., Vallejo-Díez, S., Mann, E.R., Al-Hassi, H.O., Martínez-Abad, B., Montalvillo, E., et al. IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate. Eur J Immunol 42:5 (2012), 1337–1353.
31. [31] Kitajima, S., Takuma, S., Morimoto, M., Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. Exp Anim 49:1 (2000), 9–15.
32. [32] Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487:7408 (2012), 477–481.
33. [33] Monteleone, I., Pallone, F., Monteleone, G., Aryl hydrocarbon receptor and colitis. Semin Immunopathol 35:6 (2013), 671–675.
34. [34] Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:3 (2008), 282–289.
35. [35] Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A.K., et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:2 (2008), 534–544.
36. [36] Dorofeyev, A.E., Vasilenko, I.V., Rassokhina, O.A., Kondratiuk, R.B., Mucosal barrier in ulcerative colitis and Crohn's disease. Gastroenterol Res Pract, 2013, 2013, 431231.
37. [37] Hoebler, C., Gaudier, E., De Coppet, P., Rival, M., Cherbut, C., MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice. Dig Dis Sci 51:2 (2006), 381–389.
38. [38] Quintana, F.J., Sherr, D.H., Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev 65:4 (2013), 1148–1161.
39. + regulatory T cells. Nat Immunol 4:4 (2003), 330–336.
40. [40] Quintana, F.J., Basso, A.S., Iglesias, A.H., Korn, T., Farez, M.F., Bettelli, E., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:7191 (2008), 65–71.
41. [41] Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritschler, I., Trump, S., et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478:7368 (2011), 197–203.